Jan Bultas

Agalsidase-Beta Therapy for Advanced Fabry Disease

Maryam Banikazemi, Jan Bultas, Stephen Waldek et al. · Annals of Internal Medicine · 2007 · 564 citations

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

Raphael Schiffmann, David G. Warnock, Maryam Banikazemi et al. · Nephrology Dialysis Transplantation · 2009 · 361 citations · Full text

New insights in cardiac structural changes in patients with Fabry’s disease

Aleš Linhart, Tomáš Paleček, Jan Bultas et al. · American Heart Journal · 2000 · 251 citations

Fabry ’, Cardiomyopathy, Heart Failure +11

Onset and progression of the Anderson–Fabry disease related cardiomyopathy

Christoph Kampmann, Aleš Linhart, Frank Baehner et al. · International Journal of Cardiology · 2008 · 169 citations

Cardiomyopathy, Anderson–fabry Disease, Pathology +3

Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population

Robert Dobrovolný, Lenka Dvořáková, J. Ledvinová et al. · Journal of Molecular Medicine · 2005 · 168 citations

Biology, Mendelian Disorder, Genetic Disorder +7